neelima denduluri, md, comments on the role of cdk4/6 inhibitors
Published 6 years ago • 20 plays • Length 1:19
Download video MP4
Download video MP3
Similar videos
-
2:07
neelima denduluri, md, describes how cdk 4/6 inhibitors impact breast cancer treatment
-
33:30
neelima denduluri, md -- treatment of triple negative breast cancer
-
1:59
neelima denduluri, md, discusses exciting new approaches to treating breast cancer
-
1:46
neelima denduluri, md, on how the aphinity study could impact treatment of adjuvant breast cancer
-
1:43
neelima denduluri, md, regarding the monaleesa-7 trial in premenopausal metastatic breast cancer
-
3:10
shimoli barot, md | cleveland clinic hematology & oncology
-
32:14
my cancer diagnosis - chemotherapy & almost everything in between
-
11:47
just diagnosed: breast cancer
-
14:35
all about leptomeningeal disease (lmd)
-
2:11
facing a breast cancer diagnosis: linda's story
-
1:12
neelima denduluri, md, regarding the embraca trial in her2- metastatic breast cancer
-
2:48
neelima denduluri, md, tells us about the recent updates to breast cancer guidelines
-
1:36
neelima denduluri, md, discusses outcomes from the impassion130 trial
-
1:30
neelima denduluri, md, offers opinion on the persephone trial in early her2 breast cancer
-
0:53
neelima denduluri, md, on the monaleesa-3 study in hr /her2- advanced breast cancer
-
4:24
new concepts in cdk4/6 inhibitor therapy for breast cancer
-
1:17
neelima denduluri, md, on the outcomes of the sandpiper study presented at asco 2018
-
0:38
neelima denduluri, md, considers whether the results of tailorx are practice-changing
-
2:02
dr. denduluri on the use of the oncotype dx assay in early-stage hr /her2- breast cancer
Clip.africa.com - Privacy-policy